JPMorgan reports 43.09M shares (6.1%) in Healthpeak

HEALTHPEAK PROPERTIES, INC. — JPMorgan Chase & filed a Schedule 13G reporting 43,093,473 shares beneficially owned, representing 6.1% of the class.

Rhea-AI Filing Summary

HEALTHPEAK PROPERTIES, INC. — JPMorgan Chase & filed a Schedule 13G reporting 43,093,473 shares beneficially owned, representing 6.1% of the class.

The filing lists voting and dispositive authority: sole voting power 23,807,435, shared voting power 8,058,880, sole dispositive power 34,998,291, and shared dispositive power 8,088,802. The filing is signed by a JPMorgan vice president on 05/13/2026.

Insights

Institutional Ownership Analyst

JPMorgan reports a sizable passive stake in Healthpeak Properties.

JPMorgan Chase & reports 43,093,473 shares beneficially owned, equal to 6.1% of the class as of the filing signature on 05/13/2026. The Schedule 13G lists detailed voting and dispositive breakdowns across multiple JPMorgan entities.

The holding is concentrated across several named subsidiaries, including J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC, with voting and disposal powers split between sole and shared authorities. Subsequent filings would show any material change to this position.

Key Figures

Beneficially owned: 43,093,473 shares Percent of class: 6.1% Sole voting power: 23,807,435 shares +3 more

6 metrics

Beneficially owned 43,093,473 shares Amount beneficially owned reported on Schedule 13G

Percent of class 6.1% Percent of class reported in Item 4(b)

Sole voting power 23,807,435 shares Item 4(c)(i) voting power

Shared voting power 8,058,880 shares Item 4(c)(ii) voting power

Sole dispositive power 34,998,291 shares Item 4(c)(iii) dispositive power

Shared dispositive power 8,088,802 shares Item 4(c)(iv) dispositive power

Key Terms

Schedule 13G, Beneficially owned, Dispositive power, Parent holding company

4 terms

Schedule 13G regulatory

"JPMorgan Chase & filed a Schedule 13G reporting 43,093,473 shares"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Amount beneficially owned: 43,093,473"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 34,998,291"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Parent holding company regulatory

"Identification and Classification of the Subsidiary Which Acquired the Security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does JPMorgan hold in Healthpeak Properties (DOC)?

JPMorgan reports beneficial ownership of 43,093,473 shares, representing 6.1% of the common stock. The filing shows the stake broken into sole and shared voting and dispositive powers and is dated 05/13/2026.

How is JPMorgan's voting power in DOC split?

The filing lists sole voting power of 23,807,435 shares and shared voting power of 8,058,880 shares. These figures are reported together in the Schedule 13G ownership table.

Who among JPMorgan entities is identified as holding the DOC shares?

Named subsidiaries include J.P. Morgan Trust Company of Delaware, J.P. Morgan Securities LLC, and others. The Schedule 13G attaches the list of relevant JPMorgan affiliates that hold or manage the reported position.

What dispositional authority does JPMorgan report for DOC shares?

JPMorgan reports sole dispositive power of 34,998,291 shares and shared dispositive power of 8,088,802 shares, as shown in the ownership breakdown on the Schedule 13G.

When was the Schedule 13G for DOC signed and by whom?

The Schedule 13G is signed by Rachel Tsvaygoft, Vice President on 05/13/2026. The signature block on the filing provides this attestation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 11:02 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

HEALTHPEAK PROPERTIES, INC.

(Name of Issuer)

Common Stock, $1.00 par value

(Title of Class of Securities)

42250P103

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 42250P103

1

Names of Reporting Persons

JPMORGAN CHASE & CO

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 23,807,435.00
6	Shared Voting Power 8,058,880.00
7	Sole Dispositive Power 34,998,291.00
8	Shared Dispositive Power 8,088,802.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,093,473.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.1 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: HEALTHPEAK PROPERTIES, INC.
(b)	Address of issuer's principal executive offices: 4600 SOUTH SYRACUSE STREET, SUITE 500, DENVER, COLORADO, 80237.
Item 2.
(a)	Name of person filing: JPMORGAN CHASE & CO
(b)	Address or principal business office or, if none, residence: 270 Park Avenue, New York, NY 10017
(c)	Citizenship: DE
(d)	Title of class of securities: Common Stock, $1.00 par value
(e)	CUSIP Number(s): 42250P103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 43,093,473
(b)	Percent of class: 6.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 23,807,435
	(ii) Shared power to vote or to direct the vote: 8,058,880
	(iii) Sole power to dispose or to direct the disposition of: 34,998,291
	(iv) Shared power to dispose or to direct the disposition of: 8,088,802
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. J.P. Morgan Trust Company of Delaware; J.P. Morgan Securities LLC; JPMorgan Asset Management (UK) Limited; J.P. MORGAN SE; JPMorgan Chase Bank, National Association; J.P. Morgan Investment Management Inc.; J.P. Morgan Mansart Management Limited; Security Capital Research & Management Inc.; JPMorgan Asset Management (China) Company Limited; 55I, LLC
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

JPMORGAN CHASE & CO

Signature:	Rachel Tsvaygoft
Name/Title:	Vice President
Date:	05/13/2026